Sanders Capital, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sanders Capital, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$103,585,459
-4.3%
1,073,420
+0.1%
0.22%
-3.1%
Q2 2023$108,247,166
+4.1%
1,072,710
-5.1%
0.23%
-8.1%
Q1 2023$104,008,760
+1.5%
1,130,530
+0.1%
0.25%
-8.6%
Q4 2022$102,500,899
+19.0%
1,129,860
-50.1%
0.27%
+13.5%
Q3 2022$86,105,019
-10.1%
2,263,360
+99.7%
0.24%
-2.5%
Q2 2022$95,808,000
-3.9%
1,133,420
-0.3%
0.24%
+12.0%
Q1 2022$99,740,000
+66393.3%
1,136,640
+59723.2%
0.22%
+21600.0%
Q3 2016$150,000
-49.5%
1,900
-47.2%
0.00%
-50.0%
Q2 2016$297,000
-8.9%
3,600
-20.0%
0.00%
-33.3%
Q1 2016$326,000
-15.8%
4,5000.0%0.00%
-25.0%
Q4 2015$387,000
-6.5%
4,5000.0%0.00%0.0%
Q3 2015$414,000
-6.5%
4,5000.0%0.00%0.0%
Q2 2015$443,000
-0.2%
4,5000.0%0.00%0.0%
Q1 2015$444,000
+6.5%
4,5000.0%0.00%0.0%
Q4 2014$417,000
-1.7%
4,5000.0%0.00%
-20.0%
Q3 2014$424,000
+4.2%
4,5000.0%0.01%0.0%
Q2 2014$407,000
+8.8%
4,500
+2.3%
0.01%
+25.0%
Q1 2014$374,000
+5.6%
4,4000.0%0.00%0.0%
Q4 2013$354,000
+4.7%
4,4000.0%0.00%
-20.0%
Q3 2013$338,000
+8.7%
4,4000.0%0.01%
+25.0%
Q2 2013$311,000
-0.6%
4,4000.0%0.00%
-20.0%
Q1 2013$313,000
+12.2%
4,4000.0%0.01%0.0%
Q4 2012$279,000
+3.3%
4,4000.0%0.01%0.0%
Q3 2012$270,000
+9.8%
4,4000.0%0.01%0.0%
Q2 2012$246,000
+0.8%
4,4000.0%0.01%0.0%
Q1 2012$244,000
-3.2%
4,4000.0%0.01%
-16.7%
Q4 2011$252,000
+2.9%
4,4000.0%0.01%
-14.3%
Q3 2011$245,000
-8.9%
4,4000.0%0.01%0.0%
Q2 2011$269,000
+12.6%
4,4000.0%0.01%
+16.7%
Q1 2011$239,000
+35.0%
4,400
+46.7%
0.01%
+50.0%
Q4 2010$177,0003,0000.00%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders